Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates

2021100 citationsReviewgreen Open Access

Authors

Viraraghavan Vadakkencherry Ramaswamy · University of Oxford

Tapas Bandyopadhyay · Post Graduate Institute of Medical Education and Research

Debasish Nanda · Institute of Medical Sciences and Sum Hospital

Prathik Bandiya · Indira Gandhi Institute of Child Health

Javed Ahmed · Hamad Medical Corporation

Anip Garg · James Cook University Hospital

Charles Christoph Roehr

Abstract

This study suggested that MoMdDX may be the most appropriate postnatal corticosteroid regimen for preventing BPD or mortality at a PMA of 36 weeks, albeit with a risk of hypertension. The quality of evidence was low.

Topics & Keywords

Neonatal Respiratory Health Research Congenital Diaphragmatic Hernia Studies Infant Development and Preterm Care

Publication Details

Published in: JAMA Pediatrics

Volume 175, Issue 6, pp. e206826-e206826

DOI: 10.1001/jamapediatrics.2020.6826

Field-Weighted Citation Impact: 10.86

Command Palette

Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates

Authors

Abstract

Topics & Keywords

Publication Details